J. A. Denis, A. Perrier, J. Nectoux, P. J. Lamy, A. Alary et al., Development of molecular analyzes by digital PCR for clinical practice: positioning, current applications and perspectives, Annales de Biologie Clinique, vol.77, issue.6, pp.619-637, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02992696

A. Didelot, S. K. Kotsopoulos, A. Lupo, D. Pekin, X. Li et al., Multiplex picoliter-droplet digital PCR for quantitative assessment of DNA integrity in clinical samples, Clin Chem, vol.59, issue.5, pp.815-838, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02299583

J. A. Denis, E. Guillerm, F. Coulet, A. K. Larsen, and J. M. Lacorte, The role of BEAMing and Digital PCR for multiplexed analysis in molecular oncology in the era of next-generation sequencing, Mol Diagn Ther, vol.21, issue.6, pp.587-600, 2017.

I. Kinde, J. Wu, N. Papadopoulos, K. W. Kinzler, and B. Vogelstein, Detection and quantification of rare mutations with massively parallel sequencing, Proc Natl Acad Sci U S A, vol.108, issue.23, pp.9530-9535, 2011.

D. G. Burke, L. Dong, S. Bhat, M. Forbes-smith, S. Fu et al., Digital Polymerase Chain Reaction Measured pUC19 Marker as Calibrant for HPLC Measurement of DNA Quantity, Analytical Chemistry, vol.85, issue.3, pp.1657-1664, 2013.

M. Zarrei, J. R. Macdonald, D. Merico, and S. W. Scherer, A copy number variation map of the human genome, Nat Rev Genet, vol.16, issue.3, pp.172-83, 2015.

K. M. Turner, V. Deshpande, D. Beyter, T. Koga, J. Rusert et al., Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity, Nature, vol.543, issue.7643, pp.122-127, 2017.

R. E. Handsaker, V. Van-doren, J. R. Berman, G. Genovese, S. Kashin et al., Large multiallelic copy number variations in humans, Nat Genet, vol.47, issue.3, pp.296-303, 2015.

S. Cantsilieris, P. S. Western, P. N. Baird, and S. J. White, Technical considerations for genotyping multi-allelic copy number variation (CNV), in regions of segmental duplication, BMC Genomics, vol.15, issue.1, p.329, 2014.

A. J. De-smith, K. M. Walsh, H. M. Hansen, A. A. Endicott, J. K. Wiencke et al., Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA, PLOS ONE, vol.10, issue.11, p.e0143343, 2015.

C. Williams, F. Ponten, C. Moberg, P. Soderkvist, M. Uhlen et al., A high frequency of sequence alterations is due to formalin fixation of archival specimens, Am J Pathol, vol.155, issue.5, pp.1467-71, 1999.

L. Nadauld, J. F. Regan, L. Miotke, R. K. Pai, T. A. Longacre et al., Quantitative and sensitive detection of cancer genome amplifications from formalin fixed paraffin embedded tumors with droplet digital PCR, Transl Med (Sunnyvale), vol.2, issue.2, p.1000107, 2012.

F. Z. Marques, P. R. Prestes, L. B. Pinheiro, K. Scurrah, K. R. Emslie et al., Measurement of absolute copy number variation reveals association with essential hypertension, BMC Med Genomics, vol.7, p.44, 2014.

A. A. Hedayat, K. Linos, H. S. Jung, L. J. Tafe, S. Yan et al., Evaluating melanocytic lesions with single nucleotide polymorphism (SNP) chromosomal microarray, Experimental and Molecular Pathology, vol.103, issue.3, pp.279-287, 2017.

F. Fina, D. Barets, C. Colin, C. Bouvier, L. Padovani et al., Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors, Oncotarget, vol.8, issue.2, pp.2104-2117, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01478869

R. Appay, F. Fina, N. Macagno, L. Padovani, C. Colin et al., Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas, Mod Pathol, vol.31, issue.10, pp.1490-501, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01984471

K. Cassinari, O. Quenez, G. Joly-helas, L. Beaussire, L. Meur et al., A simple, universal, and cost-efficient digital PCR method for the targeted analysis of copy number variations, Clin Chem, vol.65, issue.9, pp.1153-60, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02339190

M. C. Kline, E. L. Romsos, and D. L. Duewer, Evaluating digital PCR for the quantification of human genomic DNA: accessible amplifiable targets, Anal Chem, vol.88, issue.4, pp.2132-2141, 2016.

L. Miotke, B. T. Lau, R. T. Rumma, and H. P. Ji, High sensitivity detection and quantitation of DNA copy number and single nucleotide variants with single color droplet digital PCR, Anal Chem, vol.86, issue.5, pp.2618-2642, 2014.

A. D. Bell, C. L. Usher, and S. A. Mccarroll, Analyzing copy number variation with droplet digital PCR, Methods Mol Biol, vol.1768, pp.143-60, 2018.

Z. D. Smith and A. Meissner, DNA methylation: roles in mammalian development, Nat Rev Genet, vol.14, issue.3, pp.204-224, 2013.

M. Zuccotti, M. Grant, and M. Monk, Polymerase chain reaction for the detection of methylation of a specific CpG site in the G6pd gene of mouse embryos, Methods Enzymol, vol.225, pp.557-67, 1993.

J. G. Herman, J. R. Graff, S. Myohanen, B. D. Nelkin, and S. B. Baylin,

, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc Natl Acad Sci, vol.93, issue.18, pp.9821-9827, 1996.

C. A. Eads, K. D. Danenberg, K. Kawakami, L. B. Saltz, C. Blake et al., MethyLight: a high-throughput assay to measure DNA methylation, Nucleic Acids Res, vol.28, issue.8, p.32, 2000.

M. Yu, T. J. Heinzerling, and W. M. Grady, DNA methylation analysis using droplet digital PCR, Methods Mol Biol, vol.1768, pp.363-83, 2018.

M. Campan, D. J. Weisenberger, B. Trinh, and P. W. Laird, MethyLight and Digital MethyLight, Methods Mol Biol, vol.1708, pp.497-513, 2018.

C. A. Eads, K. D. Danenberg, K. Kawakami, L. B. Saltz, C. Blake et al., MethyLight: a high-throughput assay to measure DNA methylation, Nucleic Acids Research, vol.28, issue.8, pp.32e-0, 2000.

S. Garrigou, G. Perkins, F. Garlan, C. Normand, A. Didelot et al., A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker, Clinical Chemistry, vol.62, issue.8, pp.1129-1139, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02295782

C. M. Hindson, J. R. Chevillet, H. A. Briggs, E. N. Gallichotte, I. K. Ruf et al., Absolute quantification by droplet digital PCR versus analog real-time PCR, Nature Methods, vol.10, issue.10, pp.1003-1005, 2013.

J. Ma, N. Li, M. Guarnera, and F. Jiang, Quantification of Plasma miRNAs by Digital PCR for Cancer Diagnosis, Biomarker Insights, vol.8, p.BMI.S13154, 2013.

Y. Zeng, R. Novak, J. Shuga, M. T. Smith, and R. A. Mathies, High-performance single cell genetic analysis using microfluidic emulsion generator arrays, Anal Chem, vol.82, issue.8, pp.3183-90, 2010.

A. S. Basu, Digital assays part II: digital protein and cell assays, SLAS Technol, vol.22, issue.4, pp.387-405, 2017.

S. Olmedillas-lópez, M. García-arranz, and D. García-olmo, Current and Emerging Applications of Droplet Digital PCR in Oncology, Molecular Diagnosis & Therapy, vol.21, issue.5, pp.493-510, 2017.

B. Vogelstein, N. Papadopoulos, V. E. Velculescu, S. Zhou, and . Diaz,

K. La and . Kw, Cancer genome landscapes, Science, vol.339, issue.6127, pp.1546-58, 2013.

C. Jovelet, J. Madic, J. Remon, A. Honore, R. Girard et al., Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer, PLoS One, vol.12, issue.8, p.183319, 2017.

G. Zhu, X. Ye, Z. Dong, Y. C. Lu, Y. Sun et al., Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell?Free DNA from Patients with Advanced Non?Small Cell Lung Cancer, The Journal of Molecular Diagnostics, vol.17, issue.3, pp.265-272, 2015.

J. Madic, C. Jovelet, J. Lopez, B. André, J. Fatien et al., EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR, Oncotarget, vol.9, issue.100, pp.37393-37406, 2018.

K. S. Thress, C. P. Paweletz, E. Felip, B. C. Cho, D. Stetson et al., Acquired EGFR C797S mutation mediates resistance to AZD9291 in non?small cell lung cancer harboring EGFR T790M, Nature Medicine, vol.21, issue.6, pp.560-562, 2015.

Q. Wang, X. Yang, Y. He, Q. Ma, L. Lin et al., Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma, The Journal of Molecular Diagnostics, vol.17, issue.5, pp.515-520, 2015.

H. L. Lund, C. B. Hughesman, K. Fakhfakh, K. Mcneil, S. Clemens et al., Initial diagnosis of ALK-positive non-small-cell lung cancer based on analysis of ALK status utilizing droplet digital PCR, Anal Chem, vol.88, issue.9, pp.4879-85, 2016.

Y. Zhang, E. T. Tang, and Z. Du, Detection of MET Gene Copy Number in Cancer Samples Using the Droplet Digital PCR Method, PLOS ONE, vol.11, issue.1, p.e0146784, 2016.

R. Yoshida, T. Sasaki, Y. Umekage, S. Tanno, Y. Ono et al., Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR, BMC Cancer, vol.18, issue.1, p.1136, 2018.

P. Laurent-puig, D. Pekin, C. Norm, S. K. Kotsopoulos, P. Nizard et al., Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy, Clin Cancer Res, vol.21, issue.5, pp.1087-97, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02299577

J. B. Bachet, O. Bouche, J. Taieb, O. Dubreuil, M. L. Garcia et al., RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study, Ann Oncol, vol.29, issue.5, pp.1211-1220, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02299512

S. Garrigou, G. Perkins, F. Garlan, C. Normand, A. Didelot et al., A study of hypermethylated circulating tumor DNA as a universal colorectal cancer biomarker, Clin Chem, vol.62, issue.8, pp.1129-1168, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02295782

S. Misale, R. Yaeger, S. Hobor, E. Scala, M. Janakiraman et al., Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer, Nature, vol.486, issue.7404, pp.532-538, 2012.

C. Vandeputte, P. Kehagias, E. Housni, H. Ameye, L. Laes et al., Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor, Oncotarget, vol.9, issue.25, pp.17756-69, 2018.

M. F. Sanmamed, S. Fernandez-landazuri, C. Rodriguez, R. Zarate, M. D. Lozano et al., Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the followup of patients with melanoma being treated with BRAF inhibitors, Clin Chem, vol.61, issue.1, pp.297-304, 2015.

S. C. Tsao, J. Weiss, C. Hudson, C. Christophi, J. Cebon et al., Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations, Sci Rep, vol.5, p.11198, 2015.

E. S. Gray, H. Rizos, A. L. Reid, S. C. Boyd, M. R. Pereira et al., Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma, Oncotarget, vol.6, issue.39, pp.42008-42026, 2015.

B. Busser, J. Lupo, L. Sancey, S. Mouret, P. Faure et al., Plasma circulating tumor DNA levels for the monitoring of melanoma patients: landscape of available technologies and clinical applications, Biomed Res Int, p.5986129, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02059900

L. Keller, N. Guibert, A. Casanova, S. Brayer, M. Farella et al., Early circulating tumour DNA variations predict tumour response in melanoma patients treated with immunotherapy, Acta Derm Venereol, vol.99, issue.2, pp.206-216, 2019.

J. Charles, C. Martel, F. De-fraipont, M. T. Leccia, C. Robert et al., Mechanisms of resistance to anti-BRAF treatments, Ann Dermatol Venereol, vol.141, issue.11, pp.671-81, 2014.

H. Gevensleben, I. Garcia-murillas, M. K. Graeser, G. Schiavon, P. Osin et al., Noninvasive detection of HER2 amplification with plasma DNA digital PCR, Clin Cancer Res, vol.19, issue.12, pp.3276-84, 2013.

P. Belgrader, S. C. Tanner, J. F. Regan, R. Koehler, B. J. Hindson et al., Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue, Clin Chem, vol.59, issue.6, pp.991-995, 2013.

N. J. Heredia, P. Belgrader, S. Wang, R. Koehler, J. Regan et al., Droplet digital PCR quantitation of HER2 expression in FFPE breast cancer samples, Methods, vol.59, issue.1, pp.20-23, 2013.

T. Reinert, R. Goncalves, and J. Bines, Implications of ESR1 mutations in hormone receptor-positive breast cancer, Curr Treat Options Oncol, vol.19, issue.5, p.24, 2018.

F. Clatot, A. Perdrix, A. L. Beaussire, L. Delacour, J. Calbrix et al., prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor, Oncotarget, vol.7, issue.46, pp.74448-59, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02353218

F. Andre, E. Ciruelos, G. Rubovszky, M. Campone, S. Loibl et al., Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer, N Engl J Med, vol.380, issue.20, pp.1929-1969, 2019.

T. Takeshita, Y. Yamamoto, M. Yamamoto-ibusuki, M. Tomiguchi, A. Sueta et al., Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1 and ESR1 gene according to treatment lines in ER-positive breast cancer, Prostate Cancer Prostatic Dis, vol.17, issue.1, pp.195-205, 2018.

G. Attard and E. S. Antonarakis, Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide, Nat Rev Urol, vol.13, issue.12, pp.697-705, 2016.

V. Conteduca, D. Wetterskog, M. Sharabiani, E. Grande, M. P. Fernandez-perez et al., Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study, Ann Oncol, vol.28, issue.7, pp.1508-1524, 2017.

Y. Ma, A. Luk, F. P. Young, D. Lynch, W. Chua et al., Droplet digital PCR based androgen receptor variant 7 (AR-V7) detection from prostate cancer patient blood biopsies, Int J Mol Sci, vol.17, issue.8, p.1264, 2016.

S. T. Tagawa, E. S. Antonarakis, A. Gjyrezi, G. Galletti, S. Kim et al., Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY, Clinical Cancer Research, vol.25, issue.6, pp.1880-1888, 2018.

H. K. Woo, J. Park, J. Y. Ku, C. H. Lee, V. Sunkara et al., Urine-based liquid biopsy: non-invasive and sensitive AR-V7 detection in urinary EVs from patients with prostate cancer, Lab on a Chip, vol.19, issue.1, pp.87-97, 2019.

R. Geethakumari, P. Schiewer, M. J. Knudsen, K. E. Kelly, and W. K. , PARP inhibitors in prostate cancer, Curr Treat Options Oncol, vol.18, issue.6, p.37, 2017.

A. Wu and G. Attard, Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management, Clinical Chemistry, vol.65, issue.1, pp.100-107, 2019.

Y. Ma, A. Luk, F. P. Young, D. Lynch, W. Chua et al., Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies, International Journal of Molecular Sciences, vol.17, issue.8, p.1264, 2016.

D. N. Louis, A. Perry, G. Reifenberger, A. Von-deimling, D. Figarella-branger et al., The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathologica, vol.131, issue.6, pp.803-820, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01479018

D. J. Brat, K. Aldape, H. Colman, E. C. Holland, D. N. Louis et al., cIMPACT-NOW update 3: recommended diagnostic criteria for ?Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV?, Acta Neuropathologica, vol.136, issue.5, pp.805-810, 2018.

R. Appay, F. Fina, N. Macagno, L. Padovani, C. Colin et al., Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas, Modern Pathology, vol.31, issue.10, pp.1490-1501, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01984471

F. Fina, D. Barets, C. Colin, C. Bouvier, L. Padovani et al., Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors, Oncotarget, vol.8, issue.2, pp.2104-2113, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01478869

J. N. Honeyman, E. P. Simon, N. Robine, R. Chiaroni-clarke, D. G. Darcy et al., Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma, Science, vol.343, issue.6174, pp.1010-1014, 2014.

, afghanistan octobre, novembre, decembre 1956, Ann Biol Clin, vol.77, issue.6, p.2019, 2000.

R. P. Graham, M. M. Yeh, D. Lam-himlin, L. R. Roberts, L. Terracciano et al., Molecular testing for the clinical diagnosis of fibrolamellar carcinoma, Modern Pathology, vol.31, issue.1, pp.141-149, 2017.

R. Liu, J. Bishop, G. Zhu, T. Zhang, P. W. Ladenson et al., Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer, JAMA Oncology, vol.3, issue.2, p.202, 2017.

X. Yang, J. Li, X. Li, Z. Liang, W. Gao et al., TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer, Journal of Nuclear Medicine, vol.58, issue.2, pp.258-265, 2016.

W. J. Wang, C. F. Zheng, Z. Liu, Y. H. Tan, X. H. Chen et al., Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression, European Journal of Haematology, vol.101, issue.3, pp.291-296, 2018.

G. Fontanelli, C. Baratè, E. Ciabatti, F. Guerrini, S. Grassi et al., Real-Time PCR and Droplet Digital PCR: two techniques for detection of theJAK2V617Fmutation in Philadelphia-negative chronic myeloproliferative neoplasms, International Journal of Laboratory Hematology, vol.37, issue.6, pp.766-773, 2015.

C. F. Nystrand, W. Ghanima, A. Waage, and C. M. Jonassen, JAK2 V617F mutation can be reliably detected in serum using droplet digital PCR, International Journal of Laboratory Hematology, vol.40, issue.2, pp.181-186, 2017.

E. Lee, K. J. Lee, H. Park, J. Y. Chung, M. Lee et al., Clinical Implications of Quantitative JAK2 V617F Analysis using Droplet Digital PCR in Myeloproliferative Neoplasms, Annals of Laboratory Medicine, vol.38, issue.2, pp.147-154, 2018.

L. Anelli, A. Zagaria, N. Coccaro, G. Tota, A. Minervini et al., Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms, Annals of Hematology, vol.95, issue.9, pp.1559-1560, 2016.

G. Greiner, M. Gurbisz, F. Ratzinger, N. Witzeneder, I. Simonitsch-klupp et al., Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis, Clinical Chemistry, vol.64, issue.3, pp.547-555, 2018.

D. Drandi, E. Genuardi, I. Dogliotti, M. Ferrante, C. Jiménez et al., Highly sensitive MYD88 L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia, Haematologica, vol.103, issue.6, pp.1029-1037, 2018.

L. S. Hiemcke?jiwa, R. J. Leguit, T. J. Snijders, J. E. Bromberg, S. Nierkens et al., MYD 88 p.(L265P) detection on cell?free DNA in liquid biopsies of patients with primary central nervous system lymphoma, British Journal of Haematology, vol.185, issue.5, pp.974-977, 2018.

F. Guerrini, M. Paolicchi, F. Ghio, E. Ciabatti, S. Grassi et al., The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia, Frontiers in Pharmacology, vol.7, p.363, 2016.

D. Cilloni, J. Petiti, V. Rosso, G. Andreani, M. Dragani et al., Digital PCR in Myeloid Malignancies: Ready to Replace Quantitative PCR?, International Journal of Molecular Sciences, vol.20, issue.9, p.2249, 2019.

M. Bill, J. Grimm, M. Jentzsch, L. Kloss, K. Goldmann et al., Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients, Annals of Hematology, vol.97, issue.10, pp.1757-1765, 2018.

N. Mencia-trinchant, Y. Hu, M. A. Alas, F. Ali, B. J. Wouters et al., Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations, The Journal of Molecular Diagnostics, vol.19, issue.4, pp.537-548, 2017.

F. Albano, A. Zagaria, L. Anelli, N. Coccaro, G. Tota et al., Absolute quantification of the pretreatmentPML-RARAtranscript defines the relapse risk in acute promyelocytic leukemia, Oncotarget, vol.6, issue.15, pp.13269-13277, 2015.

Z. Liu, W. Wang, C. Zheng, Y. Tan, X. Chen et al., Clinical significance of droplet digital PCR quantitative monitoring of KIT gene mutation levels in core binding factor leukemia, International Journal of Laboratory Hematology, vol.40, issue.6, pp.e124-e126, 2018.

C. Brambati, S. Galbiati, E. Xue, C. Toffalori, L. Crucitti et al., Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation, Haematologica, vol.101, issue.4, pp.e157-e161, 2015.

L. Petrova, F. Vrbacky, M. Lanska, A. Zavrelova, P. Zak et al., IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?, Clinical Biochemistry, vol.61, pp.34-39, 2018.

D. Drandi, L. Kubiczkova-besse, S. Ferrero, N. Dani, R. Passera et al., Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma, The Journal of Molecular Diagnostics, vol.17, issue.6, pp.652-660, 2015.

D. Starza, I. Nunes, V. Cavalli, M. , D. Novi et al., Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia, Br J Haematol, vol.174, issue.4, pp.541-550, 2016.

M. Cavalli, L. A. De-novi, I. Della-starza, L. V. Cappelli, V. V. Nunes et al., Comparative analysis between RQ-PCR and digital droplet PCR ofBCL2/IGHgene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma, British Journal of Haematology, vol.177, issue.4, pp.588-596, 2017.

M. Alizadeh, M. Bernard, B. Danic, C. Dauriac, B. Birebent et al., Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction, Blood, vol.99, issue.12, pp.4618-4625, 2002.

T. Stahl, C. Rothe, M. Böhme, A. Kohl, N. Kröger et al., Digital PCR Panel for Sensitive Hematopoietic Chimerism Quantification after Allogeneic Stem Cell Transplantation, International Journal of Molecular Sciences, vol.17, issue.9, p.1515, 2016.

D. George, J. Czech, B. John, M. Yu, and L. J. Jennings, Detection and quantification of chimerism by droplet digital PCR, Chimerism, vol.4, issue.3, pp.102-108, 2013.

M. Waterhouse, D. Pfeifer, M. Follo, J. Duyster, H. Schäfer et al., Early mixed hematopoietic chimerism detection by digital droplet PCR in patients undergoing gender-mismatched hematopoietic stem cell transplantation, Clinical Chemistry and Laboratory Medicine (CCLM), vol.55, issue.8, pp.1115-1121, 2017.

A. Santurtún, J. A. Riancho, J. Arozamena, M. López-duarte, and M. T. Zarrabeitia, Indel analysis by droplet digital PCR: a sensitive method for DNA mixture detection and chimerism analysis, International Journal of Legal Medicine, vol.131, issue.1, pp.67-72, 2016.

T. Okano, Y. Tsujita, H. Kanegane, K. Mitsui-sekinaka, K. Tanita et al., Droplet Digital PCR-Based Chimerism Analysis for Primary Immunodeficiency Diseases, Journal of Clinical Immunology, vol.38, issue.3, pp.300-306, 2018.

M. Waterhouse, D. Pfeifer, J. Duque-afonso, M. Follo, J. Duyster et al., Droplet digital PCR for the simultaneous analysis of minimal residual disease and hematopoietic chimerism after allogeneic cell transplantation, Clinical Chemistry and Laboratory Medicine (CCLM), vol.57, issue.5, pp.641-647, 2019.

Y. M. Lo, N. Corbetta, P. F. Chamberlain, V. Rai, I. L. Sargent et al., Presence of fetal DNA in maternal plasma and serum, The Lancet, vol.350, issue.9076, pp.485-487, 1997.

A. Tabor and Z. Alfirevic, Update on Procedure-Related Risks for Prenatal Diagnosis Techniques, Fetal Diagnosis and Therapy, vol.27, issue.1, pp.1-7, 2010.

A. N. Barrett, B. G. Zimmermann, D. Wang, A. Holloway, and L. S. Chitty, Implementing Prenatal Diagnosis Based on Cell-Free Fetal DNA: Accurate Identification of Factors Affecting Fetal DNA Yield, PLoS ONE, vol.6, issue.10, p.e25202, 2011.

S. A. Devaney, G. E. Palomaki, J. A. Scott, and D. W. Bianchi, Noninvasive Fetal Sex Determination Using Cell-Free Fetal DNA, JAMA, vol.306, issue.6, pp.627-663, 2011.

R. Sciellour, C. Puillandre, P. Gillot, R. Baulard, C. Metral et al., Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women, Mol Diagn, vol.8, issue.1, pp.23-31, 2004.

L. Orhant, S. Rondeau, A. Vasson, O. Anselem, F. Goffinet et al., Droplet digital PCR, a new approach to analyze fetal DNA from maternal blood: application to the determination of fetal RHD genotype, Annales de biologie clinique, vol.74, issue.3, pp.269-277, 2016.

J. Nectoux, Current, Emerging, and Future Applications of Digital PCR in Non-Invasive Prenatal Diagnosis, Molecular Diagnosis & Therapy, vol.22, issue.2, pp.139-148, 2017.

L. Orhant, O. Anselem, M. Fradin, P. H. Becker, C. Beugnet et al., Droplet digital PCR combined with minisequencing, a new approach to analyze fetal DNA from maternal blood: application to the non-invasive prenatal diagnosis of achondroplasia, Prenatal Diagnosis, vol.36, issue.5, pp.397-406, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01272602

A. Gruber, M. Pacault, L. A. El-khattabi, N. A. Vaucouleur, L. Orhant et al., Non-invasive prenatal diagnosis of paternally inherited disorders from maternal plasma: detection of NF1 and CFTR mutations using droplet digital PCR, Clinical Chemistry and Laboratory Medicine (CCLM), vol.56, issue.5, pp.728-738, 2018.

F. M. Lun, N. B. Tsui, K. C. Chan, T. Y. Leung, T. K. Lau et al., Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma, Proceedings of the National Academy of Sciences, vol.105, issue.50, pp.19920-19925, 2008.

A. N. Barrett, T. C. Mcdonnell, K. C. Chan, and L. S. Chitty, Digital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia, Clinical Chemistry, vol.58, issue.6, pp.1026-1032, 2012.

N. B. Tsui, R. A. Kadir, K. C. Chan, C. Chi, G. Mellars et al., Tsui NBY, Kadir RA, Chan KCA, et al. Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood. 2011;117(13):3684?3691., Blood, vol.119, issue.19, pp.4577-4577, 2012.

D. Boeck, K. Zolin, A. Cuppens, H. Olesen, H. V. Viviani et al., The relative frequency of CFTR mutation classes in European patients with cystic fibrosis, J Cyst Fibros, vol.13, issue.4, pp.403-412, 2014.

J. Juan-mateu, L. Gonzalez-quereda, M. J. Rodriguez, M. Baena, E. Verdura et al., DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations, PLOS ONE, vol.10, issue.8, p.e0135189, 2015.

Y. M. Lo, F. M. Lun, K. C. Chan, N. B. Tsui, K. C. Chong et al.,

Y. M. Lo, F. M. Lun, K. C. Chan, N. B. Tsui, K. C. Chong et al., Digital PCR for the molecular detection of fetal chromosomal aneuploidy, Proceedings of the National Academy of Sciences, vol.104, issue.32, pp.13116-13121, 2007.

H. C. Fan, Y. J. Blumenfeld, Y. Y. El-sayed, J. Chueh, and S. R. Quake, Microfluidic digital PCR enables rapid prenatal diagnosis of fetal aneuploidy, American Journal of Obstetrics and Gynecology, vol.200, issue.5, pp.543.e1-543.e7, 2009.

L. A. El-khattabi, C. Rouillac-le-sciellour, D. Le-tessier, A. Luscan, A. Coustier et al., Could Digital PCR Be an Alternative as a Non-Invasive Prenatal Test for Trisomy 21: A Proof of Concept Study, PLOS ONE, vol.11, issue.5, p.e0155009, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01322786

D. J. Mccune, OSTEODYSTROPHIA FIBROSA, American Journal of Diseases of Children, vol.54, issue.4, p.806, 1937.

F. Albright, A. M. Butler, A. O. Hampton, and P. Smith, Syndrome Characterized by Osteitis Fibrosa Disseminata, Areas of Pigmentation and Endocrine Dysfunction, with Precocious Puberty in Females, New England Journal of Medicine, vol.216, issue.17, pp.727-746, 1937.

W. F. Schwindinger, C. A. Francomano, and M. A. Levine, Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome, Proc Natl Acad Sci, vol.89, issue.11, pp.5152-5158, 1992.

P. Romanet, P. Philibert, F. Fina, T. Cuny, C. Roche et al., Using digital droplet polymerase chain reaction to detect the mosaic GNAS mutations in whole blood DNA or circulating cell-free DNA in fibrous dysplasia and McCune-Albright syndrome, J Pediatr, vol.205, pp.281-85, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01975613

G. A. Candeliere, P. J. Roughley, and F. H. Glorieux, Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G?s from patients with fibrous dysplasia of bone, Bone, vol.21, issue.2, pp.201-206, 1997.

S. Narumi, K. Matsuo, T. Ishii, Y. Tanahashi, and T. Hasegawa, Quantitative and sensitive detection of GNAS mutations causing mccune-albright syndrome with next generation sequencing, PLoS One, vol.8, issue.3, p.60525, 2013.